Biotech - Spark Newswire

1 minute read

Amryt Pharma’s Oleogel-S10 Application Gets FDA Priority Review Tag for Skin Blistering Disorder

June 3, 8:07 AM

The FDA has granted priority review status to Amryt Pharma’s (NASDAQ:AMYT) marketing application seeking approval for Oleogel-S10 to treat Epidermolysis Bullosa (EB).…

AMYT

2 minute read

FDA
News

Hoth Therapeutics To Present Data On Preclinical Results For Its HT-KIT For mRNA Frame-Shifting On Jun. 3 at 1 p.m. EDT

By Benzinga Newsdesk

June 3, 8:06 AM

Shareholder Presentation Today to Further Highlight Results HT- KIT Reduces KIT expression and induces apoptosis of neoplastic human mast cells Inhibits tumor growth in humanized xenograft mast cell neoplasia

HOTH

1 minute read

Adaptive Biotechnologies Highlights Inclusion In Abstracts At ASCO And EHA 2021

By Bill Haddad

June 3, 7:39 AM

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, will be

ADPT

6 minute read

Replimune Provides Data Update From RP1 And RP2 Programs; Co. Also Announces Plans To Expand Development Of RP2/3 Beyond Phase 1

By Bill Haddad

June 3, 7:07 AM

Replimune Group, Inc. (NASDAQ:REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic® platform, today announced updated interim data from the Phase 2 skin cancer cohorts

REPL

3 minute read

IGM Biosciences Highlights Expansion Of IgM Platform Into Infectious Diseases; Co. Also Highlights Publication Of Preclinical Data In Nature

By Bill Haddad

June 3, 7:06 AM

MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS) a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced

IGMS

2 minute read

FDA
News

United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis

By Benzinga Newsdesk

June 3, 6:05 AM

United Therapeutics Corporation (NASDAQ:UTHR) announced today that the first patient has enrolled in the phase 3 TETON study, which is expected to evaluate approximately 396 adult patients with idiopathic pulmonary

UTHR

1 minute read

Cathie Wood Buys $6M In Intuitive Surgical, $3M In Signify Health

By Rachit Vats

June 3, 1:42 AM

Cathie Wood-led Ark Investment Management on Wednesday significantly raised its stake in Intuitive Surgical Inc (NASDAQ: ISRG) as it bought 7,259 shares of the robotic medical equipment maker, estimated to be worth about $5.96 million.

ARKG

2 minute read

What Is Going On With Clover Health Stock?

By Shivdeep Dhaliwal

June 3, 12:11 AM

Clover Health Investments Corp (NASDAQ: CLOV) spiked more than 13% on Wednesday in the regular session. What Happened: Clover Health stock shot up on a day when the so-called Stonks, or stocks favored by the retail investor crowd on social media, took the limelight.

AMC

2 minute read

Chamath Palihapitiya Launches 4 New Biotech SPACs: What Investors Should Know

By Chris Katje

June 2, 9:27 PM

One of the most famous voices in the SPAC industry is launching four new SPACs and also making several changes to his existing lineup of SPACs and former SPACs. What Happened: Chamath Palihapitiya is launching four new SPACs targeting the biotechnology sector. Each SPAC is seeking to raise $200 million and will not contain warrants.

CLOV

1 minute read

Alpine Immune Sciences Says Presents ALPN-303 Data During 2021 EULAR Virtual Meeting

By Benzinga Newsdesk

June 2, 4:05 PM

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today made an oral presentation of

ALPN